AccessibilityHelp

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Prosper Junior Bakiny

TMFPBakiny

Prosper Junior Bakiny is a contributing Motley Fool healthcare analyst covering biotechnology, pharmaceuticals, and healthcare stocks. Before The Motley Fool, Prosper wrote about investing topics ranging from stock market news to private equity for various companies. He holds a master’s degree in corporate finance from the University of Maryland Global Campus.

Recent Articles by Prosper Junior Bakiny

Person using a CGM system

Nov 11, 2025 by Prosper Junior Bakiny

1 Spectacular Growth Stock Down 20% to Buy Right Now, According to Wall Street

Shares are near their lowest levels in five years.

Warren Buffett 1 TMF 2015

Nov 11, 2025 by Prosper Junior Bakiny

24.7% of Warren Buffett's $315 Billion Portfolio at Berkshire Hathaway Is Invested in These 2 Unstoppable Stocks

They have already delivered outstanding returns to Buffett and other long-term shareholders, but it's not too late to get in on the fun.

Person packing shipping boxes

Nov 10, 2025 by Prosper Junior Bakiny

Amazon Stock Just Hit an All-Time High: Is It Too Late to Buy the Stock?

The tech leader flexed its growth muscles again in its latest quarterly update.

Person sitting at a desk looking at two monitors

Nov 10, 2025 by Prosper Junior Bakiny

2 Top Dividend Stocks to Buy and Hold Forever

These companies have already handsomely rewarded longtime shareholders, and it's not too late to join the party.

Patient self-administering a shot

Nov 10, 2025 by Prosper Junior Bakiny

2 Monster Stocks in the Making

There might still be time to get in on the ground floor.

A person working on a laptop

Nov 10, 2025 by Prosper Junior Bakiny

Could Buying Alphabet Today Set You Up for Life?

The company is firing on all cylinders right now.

Couple watching TV

Nov 9, 2025 by Prosper Junior Bakiny

1 Stock-Split Stock to Buy Before It Soars 22%, According to Wall Street

The stock is still up more than 20% year to date, but the recent dip offers an attractive buying opportunity.

Person working at a desk.

Nov 8, 2025 by Prosper Junior Bakiny

Apple Is Berkshire Hathaway's Largest Holding by Value. But Is the California-Based Company Still a Strong Play for Long-Term Growth?

Buffett and his team's confidence in this stock isn't misplaced.

Doctor and patient talking.

Nov 8, 2025 by Prosper Junior Bakiny

2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

These companies are slowly coming into their own.

Person raising two fists in the air.

Nov 8, 2025 by Prosper Junior Bakiny

This Unstoppable Growth Stock Just Gave Investors More Reasons to Buy

The stock didn't stay down for too long.

Couple shopping in a retail store

Nov 8, 2025 by Prosper Junior Bakiny

2 No-Brainer Dividend Stocks to Buy With $100 in November

There's no need to break the bank to get your hands on excellent dividend payers.

Pharmacist talking to patient

Nov 8, 2025 by Prosper Junior Bakiny

Can CVS Health Maintain Its Growth Through the End of 2025?

The company's prospects are looking up.

Pharmacist talking to patient

Nov 8, 2025 by Prosper Junior Bakiny

Prediction: Eli Lilly Will Be Worth More Than Berkshire Hathaway by 2030

It could become the first trillion-dollar pharmaceutical company in the process.

Person raising two fists in the air.

Nov 7, 2025 by Prosper Junior Bakiny

2 Small-Cap Stocks With Far More Upside Than Any "Magnificent Seven" Stock, According to Wall Street

Wall Street may be overestimating these companies' potential.

social media networking likes Facebook Meta Instagram

Nov 7, 2025 by Prosper Junior Bakiny

1 Surefire Artificial Intelligence (AI) Stock to Buy on the Dip

The recent drop makes the stock highly attractive, relative to its growth potential.

research scientists drugs pharma biotech

Nov 4, 2025 by Prosper Junior Bakiny

3 Things Investors Need to Know About Recursion Pharmaceuticals

Can this under-the-radar stock be a great way to cash in on AI?

Couple watching TV

Nov 4, 2025 by Prosper Junior Bakiny

3 Reasons to Buy Netflix Stock

The recently announced stock split isn't one of them.

Patient on a telehealth consultation.

Nov 3, 2025 by Prosper Junior Bakiny

Is This Beaten-Down Stock Finally on the Road to Recovery?

The company's headwinds don't seem to be going away.

Patient self-administering a shot

Nov 3, 2025 by Prosper Junior Bakiny

Did Novo Nordisk Just Say "Checkmate" to Pfizer?

These two leading drugmakers are fighting over a promising GLP-1 candidate.

Doctor and patient talking.

Nov 3, 2025 by Prosper Junior Bakiny

2 Beaten-Down Stocks That Could Be About to Rally

It would be best to get in before the rest of the market pounces on these opportunities.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services